Abstract
N-Substituted tetrazole was attempted to formylate which led to the formation of a novel triazene by opening of tetrazole ring via unusual Vilsmeir-Haack reaction. The formed product was proved by spectral analyses and X-Ray diffraction studies.
Keywords: Sydnone, triazole, terazole, formylation, iminium cation, Vilsmeir-Haack reaction.
Letters in Organic Chemistry
Title:Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes
Volume: 12 Issue: 2
Author(s): Atukuri Dorababu, Ravindra R. Kamble, H. C. Devarajegowda and Gangadhar Y. Meti
Affiliation:
Keywords: Sydnone, triazole, terazole, formylation, iminium cation, Vilsmeir-Haack reaction.
Abstract: N-Substituted tetrazole was attempted to formylate which led to the formation of a novel triazene by opening of tetrazole ring via unusual Vilsmeir-Haack reaction. The formed product was proved by spectral analyses and X-Ray diffraction studies.
Export Options
About this article
Cite this article as:
Dorababu Atukuri, R. Kamble Ravindra, Devarajegowda H. C. and Y. Meti Gangadhar, Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes, Letters in Organic Chemistry 2015; 12 (2) . https://dx.doi.org/10.2174/157017861202150213102528
DOI https://dx.doi.org/10.2174/157017861202150213102528 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Studies of Anticancer and Antimicrobial Activity of New
Phenylurenyl Chalcone Derivatives
Letters in Drug Design & Discovery Tubulin Inhibitors: A Patent Survey
Recent Patents on Anti-Cancer Drug Discovery Erythropoietic Porphyrias: Animal Models and Update in Gene-Based Therapies
Current Gene Therapy Pyridine Based Antitumour Compounds Acting at the Colchicine Site
Current Medicinal Chemistry Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment
Current Signal Transduction Therapy HSP60 as a Drug Target
Current Pharmaceutical Design Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Current Pharmaceutical Design Bioactive Compounds Containing Benzoxadiazole, Benzothiadiazole, Benzotriazole
Current Bioactive Compounds Innovative Drug Delivery Systems for the Administration of Natural Compounds
Current Bioactive Compounds Personalized Medicine in Oncology: A Personal View with Myths and Facts
Current Clinical Pharmacology Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues
Recent Patents on Anti-Cancer Drug Discovery From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Meet Our Editorial Board Member
Current Stem Cell Research & Therapy Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas
Current Drug Discovery Technologies Composite Lymphomas: A Challenging Entity
Current Cancer Therapy Reviews Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Current Drug Targets PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets